Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine

CEN Case Reports
Keiji HiraiKaoru Tabei

Abstract

A 42-year-old man with end-stage renal failure had been receiving hemodialysis therapy since April 2009. Initially, darbepoetin alfa was administered to treat his renal anemia. After treatment was switched to epoetin beta pegol, the patient's hemoglobin levels rapidly decreased. He was diagnosed with pure red cell aplasia (PRCA) based on the results of a bone marrow examination. Epoetin beta pegol was strongly suspected to be the cause of the PRCA, and although he tested negative for anti-epoetin beta pegol antibodies, epoetin beta pegol was discontinued and cyclosporine therapy was initiated. Thereafter, his hemoglobin levels increased, and his anemia dramatically improved after 3 months.

References

Nov 1, 1991·DICP : the Annals of Pharmacotherapy·M A Touchette, R L Slaughter
Jan 1, 1983·International Archives of Allergy and Applied Immunology·A W Richter, E Akerblom
Feb 13, 2001·British Journal of Haematology·P FischH E Schaefer
Feb 15, 2002·The New England Journal of Medicine·Nicole CasadevallPatrick Mayeux
Oct 1, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Yasushi TanumaHidenori Takashima
Oct 7, 2004·The American Journal of Medicine·Murat O ArcasoyMichael A Heneghan
Apr 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Robin Thorpe, Steven J Swanson
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Henning BlumeBarbara S Schug
May 31, 2008·British Journal of Haematology·Kenichi SawadaMakoto Hirokawa
Jul 11, 2008·American Journal of Hematology·Yuji MiuraTsunehiko Komatsu
Oct 17, 2008·Experimental Hematology·Steve ElliottIain C Macdougall
Jan 14, 2010·Biotechnology Journal·Simona JevsevarVladka Gaberc Porekar
Apr 30, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yin-Jue WangZhi-Guo Su
Jul 24, 2010·Clinical and Experimental Nephrology·Daisuke KatagiriFumihiko Hinoshita
May 7, 2011·World Journal of Gastroenterology : WJG·Cheng-Shyong ChangChien-Yu Tsai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

[Rinshō ketsueki] The Japanese journal of clinical hematology
T UchidaS Kariyone
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Rebecca Howman, Hemant Kulkarni
The Journal of the Association of Physicians of India
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Parnell MattisonDouglas M Silverstein
© 2022 Meta ULC. All rights reserved